Idm Pharma, Inc.
Records under this name other than patents Idm Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,556,943 | Hla-Dr Binding Peptides and Their Uses Formerly held In force · High confidence | In force | High confidence | |
| US 8,017,745 | Plasmodium falciparum antigens and methods of use Formerly held Term ended Term ended Aug 30, 2026 · From the USPTO record | Term ended | Term ended Aug 30, 2026 | From the USPTO record |
| US 8,741,576 | Heteroclitic analogs and related methods Formerly held Term ended Term ended Jun 22, 2025 · From the USPTO record | Term ended | Term ended Jun 22, 2025 | From the USPTO record |
| US 8,007,810 | HLA-A2 Tumor Associated Antigen Peptides and Compositions Formerly held Term ended Term ended Apr 16, 2024 · High confidence | Term ended | Term ended Apr 16, 2024 | High confidence |
| US 7,572,882 | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions Formerly held Term ended Term ended Nov 2, 2023 · From the USPTO record | Term ended | Term ended Nov 2, 2023 | From the USPTO record |
| US 7,026,443 | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions Formerly held Term ended Term ended Mar 26, 2022 · From the USPTO record | Term ended | Term ended Mar 26, 2022 | From the USPTO record |
| US 7,462,354 | Method and system for optimizing minigenes and peptides encoded thereby Formerly held Term ended Term ended Jan 26, 2021 · From the USPTO record | Term ended | Term ended Jan 26, 2021 | From the USPTO record |
| US 6,419,931 | Compositions and methods for eliciting CTL immunity Formerly held Term ended Term ended Jul 16, 2019 · From the USPTO record | Term ended | Term ended Jul 16, 2019 | From the USPTO record |
| US 6,322,789 | HLA-restricted hepatitis B virus CTL epitopes Formerly held Term ended Term ended Nov 27, 2018 · From the USPTO record | Term ended | Term ended Nov 27, 2018 | From the USPTO record |
| US 7,252,829 | HLA binding peptides and their uses Formerly held Term ended Ended no later than Jun 17, 2018 · From the USPTO record | Term ended | Ended no later than Jun 17, 2018 | From the USPTO record |